Provenienza dei contatti di primo grado di Ian Rentsch
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Miscellaneous Commercial Services | 20 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Ian Rentsch tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Corporate Officer/Principal | |
| QIAGEN N.V. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
| BAYER AG | Pharmaceuticals: Major | Sales & Marketing | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chief Executive Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
| IKARIA, INC. | Biotechnology | Chief Executive Officer | |
| SHIRE | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact | |
| EVOTEC SE | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
| RECORDATI | Pharmaceuticals: Major | Chairman Director/Board Member | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
Astion Pharma A/S
 Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Astion Pharma A/S develops and manufactures pharmaceutical products. It focuses on developing anti-inflammatory drugs for dermatological and immunological diseases. The company was founded by Morten S. Weidner in 1992 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Credit Suisse Securities (Europe) Ltd.
 Credit Suisse Securities (Europe) Ltd. Investment Banks/BrokersFinance Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors. | Investment Banks/Brokers | Corporate Officer/Principal | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chairman | |
Euronext Paris SA
 Euronext Paris SA Investment Banks/BrokersFinance Euronext Paris SA operates as a stock exchange which provides solutions for regulated stock and derivatives markets in France. Its services include facilitating public offerings, providing trading facilities for cash and derivatives products, and supplying market data. The company was founded on January 20, 1988 and is headquartered in Courbevoie, France. | Investment Banks/Brokers | Director/Board Member | |
| Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Doctorate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin | |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Aventis Pharma AG | Corporate Officer/Principal | ||
| University of Nice Sophia Antipolis | College/University | Doctorate Degree | |
| Hoechst Marion Roussel, Inc. | Corporate Officer/Principal | ||
| Merck & Co., Inc. /Cherokee Chemical Manufacturing Plant/ | Chemicals: Major Diversified | Corporate Officer/Principal | |
| Life Cycle Pharma A/S | Chief Executive Officer | ||
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| Université d'Aix-Marseille | College/University | Doctorate Degree | |
| Harvard T.H. Chan School of Public Health | College/University | Graduate Degree | |
GenePOC, Inc.
 GenePOC, Inc. Medical SpecialtiesHealth Technology GenePOC, Inc. develops rapid molecular devices to detect genes at point-of-care. Its product includes an integrated portable instrument for the prevention and early detection of infectious diseases based on a centripetal technology platform. Its product also includes GenePOC disposable, a device for performing nucleic acid-based diagnostics at POC. The company’s products are also used for infectious disease, rapid food microbiology, and human pharmacogenetic testing applications. The company was founded by Michel G. Bergeron in 2007 and is headquartered in Quebec, Canada. | Medical Specialties | Director/Board Member | |
| Galderma Benelux BV | Chief Executive Officer | ||
Sanofi-Aventis Groupe SA
 Sanofi-Aventis Groupe SA Financial ConglomeratesFinance Sanofi-Aventis Groupe SA operates as a holding company, with interest in the manufacture and distribution of pharmaceutical products. The company was founded on December 19, 1995 and is headquartered in Paris, France. | Financial Conglomerates | Corporate Officer/Principal | |
Centogene AG
 Centogene AG Medical/Nursing ServicesHealth Services Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany. | Medical/Nursing Services | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Galderma Holding SA
 Galderma Holding SA Pharmaceuticals: MajorHealth Technology Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
| CareVentures SA | Investment Managers | Chairman | |
| Careventures SA (Belgium) | Founder | ||
| Caret SRL | Director/Board Member | ||
| ARZ SRL /BE/ | Director/Board Member | ||
| ABSCI CORPORATION | Biotechnology | Corporate Officer/Principal | |
| ACER THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| CYCLERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Zeneca AGro Gmbh | Sales & Marketing |
Statistiche
Distribuzione geografica
| Stati Uniti | 11 |
| Germania | 11 |
| Francia | 8 |
| Danimarca | 6 |
| Paesi Bassi | 4 |
Settori
| Health Technology | 25 |
| Consumer Services | 7 |
| Finance | 6 |
| Commercial Services | 3 |
| Process Industries | 2 |
Posizioni
| Director/Board Member | 157 |
| Chairman | 74 |
| Corporate Officer/Principal | 44 |
| Chief Executive Officer | 24 |
| Independent Dir/Board Member | 20 |
Contatti più connessi
| Insiders | |
|---|---|
| Peer Schatz | 83 |
| Flemming Ørnskov | 34 |
| Hubert Birner | 27 |
| Berndt A. E. Modig | 23 |
| Eric Souêtre | 17 |
| Guido Prehn | 17 |
| Kim Stratton | 14 |
| Andreas Busch | 11 |
| Holger Friedrich | 10 |
| Jonathan Sheldon | 9 |
| Peter Bauer | 5 |
| Bettina Goerner | 5 |
| Patrice P. Denefle | 4 |
| Miguel Coego Rios | 4 |
| Lennart Streibel | 2 |
- Borsa valori
- Insiders
- Ian Rentsch
- Connessioni Società